University of Michigan
Publications
Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease
Liver Biopsy in the Real World—Reporting, Expert Concordance and Correlation with a Pragmatic Clinical Diagnosis
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study
23
Total Publications
10
Abstract/Manuscript
13
Poster Presentation
2023 · Poster Presentation · University of Birmingham / NIHR Birmingham BRC · Hepatology
NASH Progression Rates Based on Fibrosis and Inflammation (NAS): A Paired Biopsy Analysis From a Natural History Cohort in the US
Read more →2022 · Abstract/Manuscript · Emory
Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease
Read more →2021 · Abstract/Manuscript · Heinrich Heine University Düsseldorf
Liver Biopsy in the Real World—Reporting, Expert Concordance and Correlation with a Pragmatic Clinical Diagnosis
Read more →2021 · Abstract/Manuscript · Heinrich Heine University Düsseldorf
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study
Read more →2021 · Abstract/Manuscript · University of Michigan
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study
Read more →2021 · Abstract/Manuscript · University of Michigan
Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort
Read more →2021 · Abstract/Manuscript · Zucker School of Medicine at Hofstra
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV
Read more →2020 · Poster Presentation · Heinrich-Heine University Düsseldorf · Hepatology
Heterogeneous Documentation and Poor Concordance of NASH Pathology May Limit its Clinical Utility in Real-World Practice
Read more →2020 · Abstract/Manuscript · University of Michigan
Opioid Use is More Common in Non-Alcoholic Fatty Liver Disease Patients with Cirrhosis, Higher Body Mass Index and Psychiatric Disease
Read more →2020 · Abstract/Manuscript · University of Michigan
Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases
Read more →2020 · Abstract/Manuscript · University of Michigan
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
Routinely Available Noninvasive Tests Perform Well in Identifying Patients with Advanced Fibrosis Due to NASH: Data from the TARGET-NASH Observational Cohort
Read more →2019 · Poster Presentation · Emory · Hepatology
Patient Reported Outcomes Among Pediatric Patients with Nonalcoholic Fatty Liver Disease: TARGET-NASH
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
The Prescribing Patterns and Use of Statins in Patients with Nonalcoholic Fatty Liver Disease
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
Opioid use in patients with NAFLD: prevalence and association with comorbidities and disease severity
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
Lean NAFLD patients have lower prevalence of cardiovascular, metabolic and severe liver disease compared to overweight or obese patients with NAFLD
Read more →2019 · Poster Presentation · Zucker School of Medicine at Hofstra · Hepatology
Effectiveness of Tenofovir Alafenamide in Patients with Chronic Hepatitis B Treated in Usual Clinical Practice: Results from the TARGET-HBV Observational Cohort Study (AASLD)
Read more →2018 · Poster Presentation · Columbia University Medical Center · Hepatology
Clinical Profile of Adults with Nonalcoholic Steatohepatitis (NASH) with and without Type 2 Diabetes Mellitus (T2DM)
Read more →2018 · Poster Presentation · University of Michigan · Hepatology
Nonalcoholic Fatty Liver Disease in Children in the U.S.: Clinical Characteristics of Participants Enrolled in TARGET-NASH
Read more →2018 · Poster Presentation · University of Michigan · Hepatology
Real World Evidence Showing High Rates of Cardiovascular Events in NAFLD Patients Regardless of Liver Disease (DDW)
Read more →2017 · Poster Presentation · University of Michigan · Hepatology
Sustained Elevation in Alkaline Phosphatase is Associated with Greater Disease Severity in Real World NAFLD in TARGET-NASH
Read more →2017 · Poster Presentation · University of Michigan · Hepatology